Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

(4/3/25 645a) Peritonitis


Meeting ID: 257 755 633 880
Passcode: t7WR6jQ2

Date: Apr 3, 2025 06:45 AM - 07:45 AM

Fee

$0.00

CE Hours

2.00

CE Units

0.200

Registration closes on Apr 04, 2025 11:00 PM

Activity Type

  • Application

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians

Accreditation(s)

Accreditation Council for Pharmacy Education
 WellStar Health System is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Requirements for CE Credit

Participants who attend the entire activity, complete and pass the post-test (>70%) and complete the activity evaluation will receive CE credit.
Credit will be uploaded electronically and be available in CPE Monitor after completion of required elements.

Support/Credits

No commerical support.

 

 

 

   

Meeting ID: 257 755 633 880
Passcode: t7WR6jQ2

Objectives

  • Describe the importance of intraperitoneal (IP) administration for antibiotics in PD-associated peritonitis.
  • Prepare intraperitoneal antibiotic doses accurately based on pharmacist-provided instructions and patient-specific factors.
  • List the steps in maintaining pharmacists in maintaining inventory and ensuring the availability of antibiotics and antifungal agents commonly used in PD peritonitis.

Speaker(s)/Author(s)

Hope Elrod, PharmD
Pharmacy Resident, Kennestone

Activity Number

0483-0000-25-005-L01-T
Date: 04/03/25
Time: 06:45 AM - 07:45 AM

CE Hours

1.00

Location

via MS Teams and KH
   

   

Meeting ID: 257 755 633 880
Passcode: t7WR6jQ2

Objectives

  • Describe the key updates in the 2022 ISPD guidelines for the prevention, diagnosis, and management of PD-associated peritonitis.
  • Identify the recommended empiric antibiotic regimens for PD-associated peritonitis and discuss how to tailor therapy based on culture results and local antibiograms.
  • Explain the updated definitions and classifications of peritonitis, including relapsing and refractory peritonitis.
  • Discuss strategies to reduce the risk of peritonitis, including prophylactic measures such as exit-site care and antifungal prophylaxis. therapies
  • Evaluate the indications and timing for PD catheter removal in cases of refractory or fungal peritonitis

Speaker(s)/Author(s)

Hope Elrod, PharmD
Pharmacy Resident, Kennestone

Activity Number

0483-0000-25-005-L01-P
Date: 04/03/25
Time: 06:45 AM - 07:45 AM

CE Hours

1.00

Location

via MS Teams and KH